Copyright Reports & Markets. All rights reserved.

Global Monoclonal Antibody Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Monoclonal Antibody Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Monoclonal Antibody Therapeutics
      • 1.2 Monoclonal Antibody Therapeutics Segment by Type
        • 1.2.1 Global Monoclonal Antibody Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Human
        • 1.2.3 Humanized
        • 1.2.4 Chimeric
        • 1.2.5 Others
      • 1.3 Monoclonal Antibody Therapeutics Segment by Application
        • 1.3.1 Monoclonal Antibody Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Monoclonal Antibody Therapeutics Market by Region
        • 1.4.1 Global Monoclonal Antibody Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Monoclonal Antibody Therapeutics Market Size
        • 1.5.1 Global Monoclonal Antibody Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Monoclonal Antibody Therapeutics Production (2014-2025)

      2 Global Monoclonal Antibody Therapeutics Market Competition by Manufacturers

      • 2.1 Global Monoclonal Antibody Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Monoclonal Antibody Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Monoclonal Antibody Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Monoclonal Antibody Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Monoclonal Antibody Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Monoclonal Antibody Therapeutics Market Concentration Rate
        • 2.5.2 Monoclonal Antibody Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Monoclonal Antibody Therapeutics Production Market Share by Regions

      • 3.1 Global Monoclonal Antibody Therapeutics Production Market Share by Regions
      • 3.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Monoclonal Antibody Therapeutics Production
        • 3.4.1 North America Monoclonal Antibody Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Monoclonal Antibody Therapeutics Production
        • 3.5.1 Europe Monoclonal Antibody Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Monoclonal Antibody Therapeutics Production (2014-2019)
        • 3.6.1 China Monoclonal Antibody Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Monoclonal Antibody Therapeutics Production (2014-2019)
        • 3.7.1 Japan Monoclonal Antibody Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Monoclonal Antibody Therapeutics Consumption by Regions

      • 4.1 Global Monoclonal Antibody Therapeutics Consumption by Regions
      • 4.2 North America Monoclonal Antibody Therapeutics Consumption (2014-2019)
      • 4.3 Europe Monoclonal Antibody Therapeutics Consumption (2014-2019)
      • 4.4 China Monoclonal Antibody Therapeutics Consumption (2014-2019)
      • 4.5 Japan Monoclonal Antibody Therapeutics Consumption (2014-2019)

      5 Global Monoclonal Antibody Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Monoclonal Antibody Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Monoclonal Antibody Therapeutics Price by Type (2014-2019)
      • 5.4 Global Monoclonal Antibody Therapeutics Production Growth by Type (2014-2019)

      6 Global Monoclonal Antibody Therapeutics Market Analysis by Applications

      • 6.1 Global Monoclonal Antibody Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Monoclonal Antibody Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Monoclonal Antibody Therapeutics Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.1.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Pfizer Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Bayer
        • 7.2.1 Bayer Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.2.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Bayer Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.3.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Sanofi Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Merck
        • 7.4.1 Merck Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.4.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Merck Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 GlaxoSmithKline
        • 7.5.1 GlaxoSmithKline Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.5.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Roche
        • 7.6.1 Roche Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.6.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Roche Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Novartis
        • 7.7.1 Novartis Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.7.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Novartis Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 AbbVie
        • 7.8.1 AbbVie Monoclonal Antibody Therapeutics Production Sites and Area Served
        • 7.8.2 Monoclonal Antibody Therapeutics Product Introduction, Application and Specification
        • 7.8.3 AbbVie Monoclonal Antibody Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served

      8 Monoclonal Antibody Therapeutics Manufacturing Cost Analysis

      • 8.1 Monoclonal Antibody Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Monoclonal Antibody Therapeutics
      • 8.4 Monoclonal Antibody Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Monoclonal Antibody Therapeutics Distributors List
      • 9.3 Monoclonal Antibody Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Monoclonal Antibody Therapeutics Market Forecast

      • 11.1 Global Monoclonal Antibody Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Monoclonal Antibody Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Monoclonal Antibody Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Monoclonal Antibody Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Monoclonal Antibody Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Monoclonal Antibody Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Monoclonal Antibody Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Monoclonal Antibody Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Monoclonal Antibody Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Monoclonal Antibody Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Monoclonal Antibody Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Monoclonal Antibody Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Monoclonal Antibody Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Monoclonal Antibody Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Monoclonal Antibody Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Monoclonal Antibody Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.

        The global Monoclonal Antibody Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Monoclonal Antibody Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Monoclonal Antibody Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        Bayer
        Sanofi
        Merck
        GlaxoSmithKline
        Roche
        Novartis
        AbbVie

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Human
        Humanized
        Chimeric
        Others

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now